OXFORD ASSET MANAGEMENT LLP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 55 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$169,000
-65.1%
27,968
-59.8%
0.00%
-63.6%
Q1 2019$484,000
+52.2%
69,630
-15.4%
0.01%
+37.5%
Q4 2018$318,000
+71.9%
82,289
+132.4%
0.01%
+100.0%
Q3 2018$185,000
-35.5%
35,406
-39.3%
0.00%
-33.3%
Q2 2018$287,000
-23.9%
58,330
+24.5%
0.01%
-25.0%
Q1 2018$377,00046,8460.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Western Standard LLC 869,354$2,895,0003.47%
22NW, LP 1,241,896$4,136,0002.24%
Newtyn Management, LLC 1,199,606$3,995,0001.46%
WITTENBERG INVESTMENT MANAGEMENT, INC. 186,198$620,0000.35%
Yakira Capital Management, Inc. 66,934$223,0000.10%
Sepio Capital, LP 210,534$701,0000.08%
Nantahala Capital Management 747,635$2,490,0000.08%
Watson Rebecca 3,068$10,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,700$205,0000.00%
WEBSTER BANK, N. A. 3,055$10,0000.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders